Except for one carcinosarcoma case, all patients with CNA present in ovarian cancer expressed copy number loss of either BRCA1 or BRCA2. The presence of CNA with high-grade serous carcinoma showed alterations of several genes involved in PI3K/Akt signalling. The gene discussed is BRCA2; the disease is serous adenocarcinoma.